Auxly Cannabis - CEO, Hugo Alves
CEO, Hugo Alves
Source: Canadian Lawyer
  • Auxly Cannabis (TSXV:XLY) subsidiary, Robinsons Cannabis, has gained Health Canada’s authorisation to sell dried cannabis in Canada
  • The sales license expands the company’s current product portfolio, to include artisan hand-crafted cannabis flower
  • Robinsons has been growing small-batch cannabis at its Nova Scotia facility since obtaining its initial cultivation license
  • The company expects its dried cannabis products to become available in certain Canadian provinces this summer
  • Auxly Cannabis (XLY) is up 2.35 per cent and is currently trading at C$0.44 per share

Auxly Cannabis (TSXV:XLY) subsidiary, Robinsons Cannabis, has gained Health Canada’s authorisation to sell dried cannabis in Canada.

The sales license from the authority applies to Canadian provinces and territories under the country’s Cannabis Regulations.

With the addition of artisan, hand-crafted dried cannabis flower, the license also expands Auxly’s current product portfolio. The company and its subsidiary will produce the dried cannabis for Canada’s premium craft market. 

Since obtaining an initial license for cultivation, Robinsons has been growing small-batch premium cannabis at its Nova Scotia facility. The state-of-the-art facility is 27,700 square feet and is located in Kentville. 

The subsidiary’s cannabis cultivation processes are all overseen by the company’s founder and Master Grower, Andrew Robinson. Under his supervision, Robinsons boasts a uniquely premium product for connoisseurs of cannabis. 

Auxly’s CEO, Hugo Alves, commented on receiving Health Canada’s authorisation.

“We couldn’t be more excited to obtain this sales licence for Robinsons – a key milestone for Auxly as we continue to execute our vision of being a leader in branded cannabis products.

“Congratulations to the talented team at Robinsons who are growing what I believe is the best cannabis in Canada. Also, special thanks to Health Canada for their ability to facilitate this licence in the midst of unique challenges presented by the COVID-19 pandemic,” he said.

With the sales license from Health Canada in hand, Auxly expects to make its dried cannabis products available soon. The company anticipates that its cannabis flower will be available in select Canadian provinces this summer.

Auxly Cannabis (XLY) is up 2.35 per cent and is trading at C$0.44 per share at 11:05am EDT.

More From The Market Online
Ace Valley cannabis drinks

Canopy Growth reduces term loan by US$100 million

Cannabis leader Canopy Growth (TSX:WEED) makes an early US$100 million prepayment under its senior secured term loan.
Cannabis leaves with Stock Talk and Cannabis Report labels

The Market Online’s Weekly Cannabis Report – Oct. 11, 2024

A global cannabis company confirmed this week that its U.S.-based holding company has completed its acquisition of a cannabis edibles leader.
Tilray Brands products and logo

Tilray shows upward momentum with Q1 2025 results

Cannabis stock Tilray Brands (TSX:TLRY) posts improved financial results in Q1 2025 across gross profit, net losses and beverage revenue.
Charlotte's Web's CBD Rest gummies

Buzz on the Bullboards: Despite energy woes, TSX hits new high

The TSX's notable fluctuations this week included a new high in intraday trading. Technology has been a significant driver of these gains.